跳至主要内容
临床试验/ISRCTN70365169
ISRCTN70365169已完成未知

Computer Assisted Management of Early Rheumatoid Arthritis-II: Does prednisone inhibit progression of joint damage if early RA is treated very intensively with disease modifying antirheumatic drugs (DMARDs)?

niversity Medical Center Utrecht0 个研究点目标入组 220 人开始时间: 2006年3月29日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
220

研究概览

简要总结

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Rheumatoid Arthritis, defined according to the revised American College of Rheumatology (ACR) criteria for Rheumatoid Arthritis
  • 2. A disease duration of less than 1 year, estimated by the rheumatologist
  • 3. Age >18 years
  • 4. No previous treatment with DMARDs or oral glucocorticoids
  • 5. Written informed consent by the patient

排除标准

  • 1. Abnormal renal function (Cockroft <75 ml/min)
  • 2. Abnormal liver function (aspartate aminotransferase [ASAT]/alanine aminotransferase [ALAT] >2 x normal), active or recent hepatitis, cirrhosis
  • 3. Major co-morbidities like malignancies, severe diabetic mellitus, severe infections, severe cardio and/or respiratory diseases
  • 4. Leukopenia and/or thrombocytopenia
  • 5. Inadequate birth control contraception, pregnancy, and/or breastfeeding
  • 6. Treatment with cytoxic or immunosuppressive drugs within a period of 3 months prior to the study
  • 7. Alcohol intake >2 units per day or drug abuse, presently or in the past
  • 8. Psychiatric or mental disorders which makes adherence to the study protocol impossible
  • 9. Taking part in another clinical trial
  • 10. Osteoporotic vertebral fractures

研究者

相似试验